3619-74-7

Usage

Uses

Used in Pharmaceutical Research:
1-Propyl-1,4-diazepane is used as a building block in pharmaceutical research for the preparation of various compounds. Its unique structure and properties make it a valuable component in the development of new drugs and therapeutic agents.
Used in Organic Synthesis:
1-Propyl-1,4-diazepane is used as a versatile chemical in organic synthesis, allowing for the creation of a wide range of compounds with diverse applications.
Used in Medical Applications:
1-Propyl-1,4-diazepane is being studied for its anesthetic properties, with potential applications in the medical industry for pain management and surgical procedures.
Used in Antimicrobial Applications:
1-Propyl-1,4-diazepane may have potential antibacterial and antifungal properties, making it a candidate for use in the development of new antimicrobial agents to combat resistant infections.

InChI:InChI=1/C8H18N2/c1-2-6-10-7-3-4-9-5-8-10/h9H,2-8H2,1H3

Upstream product

• 497-19-8 sodium carbonate 
• 599-91-7 propyl tosylate 

Relevant academic research and scientific papers

2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use

The present invention provides substituted dibenzoxazepine and dibenzthiazepine compounds of Formula I: STR1 which are useful as analgesic agents for the treatment of pain, and for prostaglandin-E2 mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal, and a method for treating prostaglandin-E2 mediated diseases in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.

2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use

The present invention provides substituted dibenzoxazepine and dibenzthiazepine compounds of Formula I: STR1 which are useful as analgesic agents for the treatment of pain, and for prostaglandin-E2 mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal, and a method for treating prostaglandin-E2 mediated diseases in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.